Forbes July 28, 2021
Amy Feldman

Bill Gates-backed Vicarious Surgical, which is set to go public in a SPAC deal, hopes to reach $1 billion in revenue by 2027 as it takes on the Goliath of surgical robots.

By Amy Feldman with Aayushi Pratap

As a kid, Adam Sachs, cofounder and CEO of Vicarious Surgical, watched the 1966 science-fiction movie Fantastic Voyage and was enamored of the premise of microscopic surgeons who performed surgery inside a scientist’s brain. “Humans are the wrong size to operate on humans,” he says. “We’re not going to shrink humans down, but we can create avatars of them. We can create little miniature robotic versions.”

That’s just what he and his Vicarious Surgical cofounders—Sammy Khalifa, the company’s chief technology officer,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Provider, Robotics/RPA, Technology, Trends
Less pain, quicker recoveries: 1 year of University Hospitals' robotics push
Here’s The Second Humanoid Robot To Get A Paying Job
CES 2025: 20 Tech Experts Predict Highlights And Trends
Study explores factors influencing acceptance of home-care robots
FHC #157: NVIDIA expects AI, robots to cure healthcare’s biggest problems

Share This Article